Abstract

Background Chemotherapy-induced peripheral neuropathy (CIPN) is a common adverse effect in cancer patients. The aim of this review was to assess the effectiveness of herbal medicine in preventing and treating CIPN. Methods Randomised controlled trials were included in this review. Extracting and assessing the data independently, two authors searched 13 databases. Results Twenty-eight trials involving 2174 patients met the inclusion criteria. Although there were some exceptions, the methodological quality was typically low. Seventeen trials reported the incidence rate of CIPN assessed by various tools and 14 showed a significant difference regarding the decrease of the incidence rate between the two groups. For clinical improvement, 12 trials reported it using various tools and 10 showed a significant difference between two groups. Two cases of adverse events occurred in one trial; the other nine trials reported no adverse events. Conclusions We found that herbal medicines in combination with and/or without other therapies potentially have preventive or therapeutic effects on CIPN. However, conclusions cannot be drawn because of the generally low quality of the methodology, the clinical heterogeneity, and the small sample size for each single herbal medicine. Trials that are more rigorous and report sufficient methodological data are needed.

Highlights

  • Chemotherapy induced peripheral neuropathy (CIPN) is a common and stubborn adverse effect of chemotherapy agents such as platinum agents, taxanes, vinca alkaloids, epothilones, thalidomide, and bortezomib [1, 2]

  • We conducted this systematic review to assess the effectiveness of herbal medicine for Chemotherapy-induced peripheral neuropathy (CIPN) in cancer patients

  • Eighteen of the included trials investigated the preventive effects of herbal medicines, and ten trials tested the therapeutic effects of herbal medicines

Read more

Summary

Introduction

Chemotherapy induced peripheral neuropathy (CIPN) is a common and stubborn adverse effect of chemotherapy agents such as platinum agents, taxanes, vinca alkaloids, epothilones, thalidomide, and bortezomib [1, 2]. Chemotherapy-induced peripheral neuropathy (CIPN) is a common adverse effect in cancer patients. The aim of this review was to assess the effectiveness of herbal medicine in preventing and treating CIPN. Seventeen trials reported the incidence rate of CIPN assessed by various tools and 14 showed a significant difference regarding the decrease of the incidence rate between the two groups. 12 trials reported it using various tools and 10 showed a significant difference between two groups. Conclusions cannot be drawn because of the generally low quality of the methodology, the clinical heterogeneity, and the small sample size for each single herbal medicine. Trials that are more rigorous and report sufficient methodological data are needed

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call